Quantification of endothelial permeability, leakage space, and blood volume in brain tumors using combined T1 and T2* contrast-enhanced dynamic MR imaging
- 1 June 2000
- journal article
- clinical trial
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 11 (6) , 575-585
- https://doi.org/10.1002/1522-2586(200006)11:6<575::aid-jmri2>3.0.co;2-1
Abstract
This study describes a method for imaging brain tumors that combines T1-weighted (T1W) and T2*-weighted (T2*W) dynamic contrast-enhanced acquisitions. Several technical improvements have been made to produce high-quality three-dimensional mapping of endothelial permeability surface area product (k) and leakage space (vl), based on T1W data. Tumor blood volume maps are obtained from T2*W images with a complete removal of residual relaxivity effects. The method was employed in 15 patients with brain tumors (5 gliomas, 5 meningioma, and 5 acoustic schwannoma). Mean values of vl were significantly greater in acoustic schwannomas (53% +/- 9%) than in meningiomas (34% +/- 7%) or gliomas (22% +/- 4%). Mean values of vl in meningioma were significantly greater than those of gliomas. Mean values of rCBV correlated closely with k. There was also a positive correlation between k and vl for pixels with low k values. This relationship was weaker in areas of high k. The highest mean ratios of k to vl (k(ep)) were seen in two patients with glioblastoma, one patient with transitional cell meningioma, and one patient with angioblastic meningioma. Pixel-by-pixel comparison showed a strong correlation between rCBV and k in 11 of 15 patients. However, decoupling between pixel-wise rCBV and k was found in four patients who had lesions with moderate k and vl elevation but no increase of rCBV. Results from this study suggest that in assessing the angiogenic activities in brain tumors it is advisable to monitor simultaneously changes in tumor blood volume, vessel permeability, and leakage space of tumor neovasculature.Keywords
This publication has 34 references indexed in Scilit:
- Tumor angiogenesis - a new therapeutic target in gliomasActa Neurologica Scandinavica, 2009
- Immunohistochemical Detection of Vascular Growth Factors in Angiomatous and Atypical Meningiomas, as well as HemangiopericytomasPathology - Research and Practice, 1997
- Activator-protein-1 binding potentiates the hypoxia-induciblefactor-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cellsBiochemical Journal, 1997
- Brain Edema in Meningiomas Is Associated with Increased Vascular Endothelial Growth Factor ExpressionNeurosurgery, 1997
- Meningiomas: Role of Vascular Endothelial Growth Factor/Vascular Permeability Factor in Angiogenesis and Peritumoral EdemaNeurosurgery, 1997
- Expression and distribution of vascular endothelial growth factor protein in human brain tumorsActa Neuropathologica, 1997
- Angiogenesis in malignant gliomasGlia, 1995
- VEGF-mediated tumour angiogenesis: a new target for cancer therapyCurrent Opinion in Biotechnology, 1995
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- The vasculature of experimental brain tumours: angiogenesis, vascular pathology and permeability studiesPublished by Springer Nature ,1986